Parsabiv

Indicated For

secondary hyperparathyroidism, SHPT, chronic kidney disease on hemodialysis

About This Medication

# Amgen Safety Net Foundation Patient Guide: How to Get Parsabiv (etelcalcetide) at Low or No Cost Parsabiv (etelcalcetide) is an FDA-approved intravenous medication from Amgen used to treat **secondary hyperparathyroidism (HPT)** in adults with chronic kidney disease (CKD) on hemodialysis. The **Amgen Safety Net Foundation** program helps eligible patients access Parsabiv at low or no cost if they meet income and other requirements[1][2]. ## About Parsabiv (etelcalcetide) **Parsabiv** is a calcimimetic drug, meaning it mimics calcium to activate receptors on the parathyroid gland, reducing excess parathyroid hormone (PTH) levels. High PTH in CKD patients on dialysis can lead to bone problems, weak bones, fractures, and heart issues. Unlike oral calcimimetics like Sensipar (cinacalcet), **Parsabiv is given intravenously** by your dialysis team three times a week at the end of your hemodialysis session—easy and no pills to remember[2][3]. Clinical trials showed strong results: In two studies, 77-79% of Parsabiv patients had over 30% PTH reduction from baseline (vs. 11% on placebo), and 52-56% reached PTH ≤300 pg/mL (vs. 5-6% on placebo)[2]. It's the first new treatment for this in over a decade[2]. **Important Safety Note**: Do not use if allergic to etelcalcetide. Possible hypersensitivity reactions like rash or swelling. Always discuss risks with your doctor[2]. ## Who Qualifies for the Program? The Amgen Safety Net Foundation aids uninsured or underinsured patients with financial need. Exact details like income limits aren't specified here, but programs like this typically target those at or below **400-500% of the Federal Poverty Level (FPL)**. Contact the program for your situation[1]. **General eligibility**: - U.S. resident - Prescription for Parsabiv from a doctor - Meet income guidelines (see table below for examples) - Often for uninsured, Medicare patients without coverage, or high copays ## Income Eligibility Breakdown Amgen programs often use FPL-based thresholds. While specifics aren't listed, here's a typical breakdown for similar assistance (confirm with program as guidelines update yearly): | Household Size | Annual Income Limit (e.g., 400% FPL) | Notes | |---------------|-------------------------------------|-------| | 1 (Individual) | ~$58,320 | Adjusts yearly for inflation | | 2 (Couple) | ~$78,880 | Add ~$20,560 per extra person | | 3 | ~$99,440 | Contact for exact current limits | | 4 | ~$120,000 | May go up to 500% FPL in some cases | **Notes**: Income includes most sources but excludes some like certain assistance. Provide proof like tax returns[1]. ## Insurance Requirements - **Uninsured or underinsured** preferred. - Medicare Part D patients may qualify if they hit the "donut hole" or have high costs. - Commercial insurance: If copays exceed what you can afford. - Program bridges gaps but may require proof of insurance denial or exhaustion of benefits. Medicare patients: Parsabiv's IV administration might be covered under Part B (medical benefit), but assistance helps with remaining costs[1]. ## Step-by-Step Application Process 1. **Get your doctor's help**: Ask your nephrologist or dialysis center to confirm Parsabiv is right for you and complete the prescription. 2. **Call the program**: Dial **(800) 772-6436** Monday-Friday. A representative guides you[1]. 3. **Gather documents**: - Proof of income (tax return, pay stubs, SSI award letter) - Proof of residency (utility bill, lease) - Insurance info or denial letter - Doctor's prescription and patient consent form (sent by program) 4. **Submit application**: By mail, fax, or online (if available—call to check). Doctor's office often handles this. 5. **Wait for approval**: See timeline below. 6. **Receive medication**: Shipped to your doctor's office or dialysis center. **Tip**: Start early—your dialysis team knows this process well. ## Timeline and Delivery Processing typically takes **2-4 weeks** after complete submission, but can vary. Once approved: - Medication delivered to your healthcare provider (dialysis clinic). - Administered during dialysis—no home delivery needed. - Coverage often 1 year, renewable. ## Alternatives if Denied or Ineligible - **Other Amgen programs**: Check Amgen SupportPlus or copay cards. - **RxAssist.org**: Search for Parsabiv alternatives[1]. - **NeedyMeds/PAN Foundation**: General CKD assistance. - **Sensipar (cinacalcet)**: Oral alternative, though different administration[4]. - **State programs**: Medicaid extra help or kidney-specific aid. - **Manufacturer copay assistance**: For insured patients. - **Patient Access Network (PAN)**: Grants for hyperparathyroidism. If denied, ask why and reapply with more docs. ## Reauthorization and Refills Annual renewal required—submit updated income/insurance proof before expiration. Your doctor resubmits. ## Disclaimer This guide is for informational purposes based on available data as of 2026. Program details change; **always verify with Amgen at (800) 772-6436 or your doctor**. Not medical advice. Eligibility not guaranteed. Consult healthcare provider for treatment decisions[1][2]. (Word count: 912)

Program information last verified: March 30, 2026